NUEVAS TECNOLOGIAS EN DIABETES Y EN ENDOCRINOLOGIA SLP
Company details
- Active NIF/CIF: B91698894
-
-
-
-
Address: Not available
-
-
Featured products:
More information on NUEVAS TECNOLOGIAS EN DIABETES Y EN ENDOCRINOLOGIA SLP
-
MUÑOZ ODRIOZOLA ALEJANDROApoderado solidarioTermination of employment: 28/10/2016
-
DOMINGUEZ-RODIÑO SANCHEZ-LAULHE ELOYApoderado solidarioAppointment: 04/09/2012
-
MUÑOZ CORIOZOLA ALEJANDROApoderado solidarioAppointment: 04/09/2012
-
DOMINGUEZ- RODIÑO DE LA CUESTA MARIAApoderado solidarioAppointment: 04/09/2012
-
DOMINGUEZ-RODIÑO DE LA CUESTA MARIA DEL CARMENApoderado solidarioAppointment: 04/09/2012
Other information
The CIF of NUEVAS TECNOLOGIAS EN DIABETES Y EN ENDOCRINOLOGIA SLP is B91698894 and its current business status is active. The company is engaged in activities related to the CNAE code 8622 - Specialised medicine activities. Its SIC code - also indicates the nature of its business.
NUEVAS TECNOLOGIAS EN DIABETES Y EN ENDOCRINOLOGIA SLP employs a number of workers ranging from Between 10 and 49 employees, and records an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Sevilla and has a total of 5 registry positions.
Its last announcement in Borme was published on 28/10/2016, while its last deposit of ordinary annual accounts corresponds to the year 2021.
You can find contact information for NUEVAS TECNOLOGIAS EN DIABETES Y EN ENDOCRINOLOGIA SLP, such as phone number, address, or website, in the Company Data section.
For more details about NUEVAS TECNOLOGIAS EN DIABETES Y EN ENDOCRINOLOGIA SLP, you can review one of our available financial reports, the Annual Accounts of the company, or check its default incidents in the RAI delinquency file.
The financial, business, and legal information provided for NUEVAS TECNOLOGIAS EN DIABETES Y EN ENDOCRINOLOGIA SLP comes from official sources and is updated daily.
Do you want to know more about NUEVAS TECNOLOGIAS EN DIABETES Y EN ENDOCRINOLOGIA SLP??
Find out more about this company by consulting these reports: